Daniel Anderson

New Capabilities

Leading the in-body CAR NK research

MIT researchers have found a way to turn a patient's own natural killer (NK) immune cells into cancer-fighting cells without removing them. The technique uses lipid nanoparticles (LNPs) to deliver messenger RNA (mRNA) that instructs the cells to build chimeric antigen receptors (CARs), the targeting proteins used in CAR T therapies.

Updated 2 hours ago